Fulgent Genetics (FLGT) Operating Income Growth (3y) (2018 - 2026)
Fulgent Genetics (FLGT) Operating Income Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 9.77% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -1.04% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 12.32% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.37% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -1.16% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 12.85% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 68.50% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.10% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 19.25% |
| 10 | Fulgent Genetics | 557.44 Mn | 300.41 Mn | 25.68 Mn | -22.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.14% |
| Mar 31, 2026 | -11.73% |
| Dec 31, 2025 | -26.61% |
| Sep 30, 2025 | -257.28% |
| Jun 30, 2025 | -52.42% |
| Mar 31, 2025 | -28.02% |
| Dec 31, 2024 | -28.20% |
| Sep 30, 2024 | -28.20% |
| Jun 30, 2024 | -29.88% |
| Mar 31, 2024 | -27.68% |
| Dec 31, 2023 | -38.71% |
| Sep 30, 2023 | -85.01% |
| Jun 30, 2023 | -111.79% |
| Mar 31, 2023 | -134.95% |
| Dec 31, 2022 | 251.87% |
| Sep 30, 2022 | -38.44% |
| Jun 30, 2022 | 251.34% |
| Mar 31, 2022 | 383.13% |
| Dec 31, 2021 | 429.68% |
| Sep 30, 2021 | 475.16% |